Aurisco Pharmaceutical Co Ltd
SSE:605116
Aurisco Pharmaceutical Co Ltd
Cash from Investing Activities
Aurisco Pharmaceutical Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Aurisco Pharmaceutical Co Ltd
SSE:605116
|
Cash from Investing Activities
-¥256.8m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Cash from Investing Activities
-¥242m
|
CAGR 3-Years
52%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Investing Activities
-¥5.9B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Investing Activities
¥73.3m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Investing Activities
¥518.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
See Also
What is Aurisco Pharmaceutical Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-256.8m
CNY
Based on the financial report for Dec 31, 2022, Aurisco Pharmaceutical Co Ltd's Cash from Investing Activities amounts to -256.8m CNY.
What is Aurisco Pharmaceutical Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-12%
Over the last year, the Cash from Investing Activities growth was 2%. The average annual Cash from Investing Activities growth rates for Aurisco Pharmaceutical Co Ltd have been -46% over the past three years , -12% over the past five years .